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A Population-Based Study of the Prevalence of Fatigue
After Transient Ischemic Attack and Minor Stroke
Charlotte Winward, MSc; Catherine Sackley, PhD;
Ziyah Metha, DPhil; Peter M. Rothwell, MD, PhD, FRCP, FMedSci
Background and Purpose—Fatigue is common after stroke and can be attributable to the increased physical effort
associated with severe neurological deficits; however, its presence in those with little motor deficit raises the possibility
of confounding by other factors, such as comorbidity, anxiety, and medication. To control for such factors and determine
the extent of stroke-specific fatigue, we compared patients with minor stroke who had little or no residual neurological
deficit with patients with TIA; both groups had undergone similar investigations and treatment.
Methods—The prevalence of fatigue 6 months after TIA or minor stroke was assessed in consecutive patients using the
Chalder fatigue scale in a population-based incidence study (Oxford Vascular Study). Patients were included if they
were independent in self-care Barthel Index (18/20) and without major cognitive impairment (Mini-Mental State
Examination 24/30). Stroke severity at baseline was assessed with the National Institute of Health Stroke Scale
(NIHSS). Other potential causes of fatigue were assessed including anxiety, depression, recent life events, medication,
and abnormalities in biochemistry or hematologic tests.
Results—Seventy-six participants had minor stroke (mean age, 74.1 years; 42 men) and 73 had TIA (mean age, 72.5 years;
40 men). At 6-month follow-up, median Barthel Index score was 20 (interquartile range, 20–20) in both groups.
However, fatigue was more common after stroke than TIA (56% vs 29%; OR, 3.14; 95% CI, 1.51–6.57; P0.0008).
This difference was present both in patients with modified Rankin score of 0 at 6 months (23.8% vs 10.3%) and patients
with modified Rankin score 1 (69.2% vs 48.6%), and remained more frequent in stroke patients after adjustment for
potential confounders. Within the group of patients with stroke, the prevalence of fatigue increased with initial stroke
severity (87% NIHSS 4 vs 48% NIHSS 3; P0.0087); however, stroke patients with initial NIHSS of 0 were still
more fatigued than patients with TIA (57% vs 29%; P0.015).
Conclusions—The prevalence of fatigue after minor stroke is higher than after TIA, suggesting that it is not simply a
consequence of the stress of a recent acute cerebral event, comorbidity, medication, or other potential confounders. The
high levels of fatigue in stroke patients without neurological impairment suggest it has a central origin rather than being
the result of increased physical effort required after stroke. (Stroke. 2009;40:757-761.)
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Fatigue is a common and important cause of long-termmorbidity after stroke.1 The prevalence of fatigue after
stroke varies with time since the event and with population
types and sampling (hospital, community, and outpatient);
estimates range between 38% and 68%.2–8 Although fatigue is
important to patients9,10 and clinicians,8,11 research has been
limited,4,12,13 partly perhaps because of difficulties in measure-
ment and in disentangling the numerous potential causes.1,3,14
Both physical and mental factors contribute to fatigue.
Poststroke fatigue is associated with depression,2,6,12 motor
impairment,2,15 physical deconditioning,8,16 reduced health-
related quality of life,2,6 and increased mortality.4 However,
fatigue has also been reported in patients who are not
depressed and have little motor impairment,4,5 and it is
uncertain whether other factors, such as the stress of a
cerebral event, comorbidity, and medication, may also con-
tribute. To control for such factors, and to determine the
extent of stroke-specific fatigue, we compared patients with
recent minor stroke vs patients with a recent TIA and no
neurological deficit; both groups had undergone similar investi-
gations and treatment. To our knowledge there are no previously
published data on the prevalence of fatigue in unselected patients
with TIA and no population-based studies.
Materials and Methods
The study was nested in the Oxford Vascular Study, a population-
based study of all acute vascular events, including TIA and stroke, in
Oxfordshire, UK. The methods of Oxford Vascular Study have been
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described previously,17 and direct assessment has shown that case-
ascertainment is near complete.18 All cases were reviewed by a
neurologist to confirm the diagnoses, which were based on standard
criteria.19 A detailed clinical assessment was performed, including
the NIHSS score.20 Ethical approval for Oxford Vascular Study and
related substudies was obtained from the local ethics committee.
All patients were followed-up at 1, 6, 12, and 24 months after the
TIA or minor stroke. At the 6-month follow-up visit, a researcher
assessed fatigue in all patients who fulfilled the following eligibility
criteria: (1) TIA or stroke (ischemic or hemorrhagic) at baseline; (2)
no recurrent stroke during first 6 months of follow-up; (3) no major
nonstroke disorder (eg, cancer or acute coronary syndrome) during
first 6 months of follow-up; and (4) functionally independent at
6-month follow-up: Barthel Index score 18/20 and Mini-Mental
State Examination 24/30.
The following potential causes of fatigue were assessed: anxiety
and depression,21 recent life events, obesity (body mass index),
thyroid function, urea and electrolytes, hemoglobin, and medication.
Other potential confounders were assessed, including social circum-
stances, educational attainment, employment status, and ethnic
origin. We also measured the modified Rankin score at 6-month
follow-up.22
To determine whether the presence of fatigue was associated with
the patients’ subjective impressions of their recovery from the stroke
or TIA, we also administered the Simple Questions scale for
recovery from stroke at the 6-month follow-up.23
Fatigue was measured with the Chalder24 fatigue scale, which has
been used widely in chronic fatigue,25 multiple sclerosis,26 Gulf War
syndrome,27 migraine,28 HIV,29 and in healthy populations.30 The
score consists of 11 short questions on tiredness, energy, and the
need to rest, and it does not specifically ask about “fatigue.” As
generally recommended, a score 3 out of 11 indicates significant
fatigue.24 Several studies have shown the score to be valid and
reliable in measuring chronic fatigue.24,31,34 Data were analyzed with
the SPSS version 15.0 (SPSS Inc).
Results
Of 149 eligible participants who were approached at 6-month
follow-up, all consented to the study. Seventy-three patients
had minor stroke (67 ischemic) and 76 had TIA. Baseline
characteristics, assessed at the time of the TIA or stroke, are
shown in Tables 1 and 2. There were no significant differ-
ences in demographic characteristics, vascular risk factors,
results of relevant blood tests, education attainment, social
circumstances, employment status, anxiety and depression, or
baseline medications. There were, however, more cases of
previous stroke in the minor stroke population compared with
TIA (P0.0011; Table 1).
There were no differences at the 6-month assessment
between TIA and stroke patients in medications (Table 3),
Barthel Index, Mini-Mental State Examination, or anxiety
and depression (Table 4). However, Chalder fatigue scores at
the 6-month follow-up were significantly higher in patients
with stroke than in those with TIA (P0.0013; Figure).
Significant fatigue (3 on the Chalder fatigue scale) was
more common after stroke than after TIA (56% vs 29%
respectively; OR, 3.14; 95% CI, 1.51–6.57; P0.0008; Table
4). This difference was still present after adjusting for
previous stroke, living alone, and systolic blood pressure
(OR, 2.85; 95% CI, 1.36–5.96; P0.005), and when patients
with previous stroke were excluded from the analysis (53%
vs 30%; OR, 2.62; 95% CI, 1.21–5.70; P0.008).
Median modified Rankin score at 6 months was 1 (inter-
quartile range, 0,2) in stroke cases and 0 (interquartile range,
0,1) in TIA (P0.0002). However, when the analysis of
Table 1. Baseline Characteristics Between Strokes and TIA
Stroke, n73
n (%)
TIA, n76
n (%)
Stroke vs
TIA P
Age, median (IQR) 74.1 (64.5, 80.0) 72.5 (62.6, 82.5) 0.83
Male 42 (58%) 40 (53%) 0.62
Previous MI 7 (10%) 3 (4%) 0.20
Previous TIA 11 (15%) 12 (16%) 1.00
Previous stroke 14 (19%) 2 (3%) 0.001
Previous PVD 4 (5%) 3 (4%) 0.72
Previous angina 7 (10%) 6 (8%) 0.78
AF 7 (10%) 13 (17%) 0.23
Carotid territory
event*
43 (66%) 50 (68%) 0.86
Blood pressure
Systolic, median
(IQR)
155 (140, 171) 150.0 (130, 160) 0.05
Diastolic, median
(IQR)
83.5 (75, 94) 82.5 (72, 91) 0.46
Raised BP (systolic
140, diastolic
90)
50 (70%) 54 (71%) 1.00
Blood tests
Hemoglobin,
median (IQR)
14.0 (12.8, 15.1) 13.7 (13.2, 14.9) 0.79
Platelet, median
(IQR)
262.0 (222, 326) 255.5 (213, 286) 0.12
Sodium, median
(IQR)
138.0 (135, 140) 138.5 (137, 140) 0.57
Potassium, median
(IQR)
3.8 (3.6, 4.3) 3.9 (3.7, 4.3) 0.43
Urea, median (IQR) 5.9 (4.9, 8.0) 5.5 (4.9, 6.4) 0.15
Thyroid stimulation
hormone, median
(IQR)
1.6 (0.9, 2.2)† 1.7 (1.2, 2.3)‡ 0.17
Ethnic group 0.75
White 71 (97%) 72 (95%)
Black Caribbean 1 (1%) 1 (1%)
Black African 1 (1%) 0 (0%)
Asian 0 (0%) 2 (3%)
Chinese 0 (0%) 1 (1%)
Smoking 0.24
Never 29 (40%) 40 (53%)
Ex-smoker 33 (45%) 29 (38%)
Current 11 (15%) 7 (9%)
Diabetes 6 (8%) 5 (7%) 0.76
Alcohol units, median
(IQR)
2 (0, 10) 2 (0, 9.5) 0.82
BMI, median (IQR) 25.1 (23.1, 28.4) 25.0 (22.0, 29.4) 0.75
BMI indicates body mass index; BP, blood pressure; IQR, interquartile range;
MI, myocardial infarction; PVD, peripheral vascular disease; AF, atrial fibrillation.
P values are for Mann–Whitney U test for medians and Fisher exact test for
frequencies unless stated otherwise.
*Carotid event n65; †TSH n46; ‡TSH n57.
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fatigue was stratified by modified Rankin score at 6 months
(Table 4), the excess of fatigue among patients with stroke
(OR, 3.14; 95% CI, 1.51–6.57; P0.0008) was present in
patients with modified Rankin score of 0 (23.8% vs 10.3%;
OR, 2.73; 95% CI, 0.54–14.4) and patients with modified
Rankin score 1 (69.2% vs 48.6%; OR, 2.38; 95% CI,
0.91–6.26).
Prevalence of fatigue increased with severity of the initial
stroke (87% at NIHSS 3 vs 48% at 3; OR, 6.96; 95% CI,
1.30–49.25; P0.0087). However, patients with stroke who
had an NIHSS score of 0 in the acute phase were still more
fatigued at 6-month follow-up than those with TIA (57% vs
29%, respectively; OR, 3.19; 95% CI, 1.10–9.34; P0.015).
To determine whether the presence of fatigue was associ-
ated with the patients’ subjective impressions of their recov-
ery from the stroke or TIA, we asked the “Simple
Questions.”23
Patients who felt that they had not made a full recovery
were significantly more likely to be fatigued than those who
had made a full recovery (37/51 vs 30/103; P0.0001), and
although patients with stroke were more likely than those
with TIA to state that they had not fully recovered (Table 4),
the association between lack of subjective recovery and
fatigue was still present when the analysis was confined to
those with stroke only (33/44 vs 10/32; P0.0001).
Discussion
This population-based study of fatigue in consecutive cases
of minor stroke and TIA is the first to our knowledge to report
data on the prevalence of fatigue in TIA patients. Previous
studies3,32 have often specifically excluded patients with TIA.
One of the strengths of our study is the comparison of TIA
and minor stroke cases. Even though the study was confined
to patients who had relatively minor strokes with sufficient
recovery to be independent in self-care, patients with minor
stroke reported significantly higher levels of fatigue at
6-month follow-up than those with TIA. This difference was
independent of measured potential confounders for fatigue,
including anxiety, depression, recent life events, relevant
blood tests, and medication, suggesting that the excess of
fatigue in patients with minor stroke reflected a causal
association. Although fatigue can be related to the increased
physical effort associated with severe neurological deficits,
our stroke patients had little or no motor deficit, suggesting
that their excess of fatigue compared with TIA patients was
attributable to central mechanisms.
Other studies have also reported high rates of fatigue
during follow-up after stroke. In a Swedish study of all
community and hospital first-ever strokes, Appelros et al33
found that 53% reported fatigue at 1 year after stroke, which
is consistent with our rate of 56% at 6 months. Also
Table 2. Baseline Demographic, Social, and Psychological
Characteristics
Stroke, n73
n (%)
TIA, n76
n (%)
Stroke vs TIA
P
Education 0.71
Basic 47 (66%) 45 (59%)
Further 13 (18%) 17 (22%)
Higher 11 (15%) 14 (18%)
Age left school, median (IQR) 15 (14, 16.5) 15 (14, 17) 0.50
Age left education, median
(IQR)
15 (14, 18)* 16 (15, 20) 0.26
Social circumstances
Living at home 66 (92%) 73 (97%) 0.16
Living alone 16 (22%) 28 (37%) 0.07
Carer 6 (8%) 2 (3%) 0.16
Marital status 0.19
Married 49 (67%) 38 (50%)
Widowed 15 (21%) 23 (30%)
Single 2 (3%) 1 (1%)
Separated 5 (7%) 11 (14%)
Partner 2 (3%) 3 (4%)
Employment 0.25
Working full-time 11 (15%) 13 (17%)
Working part-time 2 (3%) 7 (9%)
Caring for home 0 (0%) 2 (3%)
Unemployed 0 (0%) 1 (1%)
Unable to work 3 (4%) 2 (3%)
Retired 56 (78%) 50 (67%)
Interviewer’s perception of
patient’s personality
0.16
Very relaxed 4 (6%) 9 (12%)
Fairly relaxed 33 (46%) 34 (46%)
Average 21 (30%) 18 (24%)
Prone to stress 13 (18%) 9 (12%)
Patient’s perception of own
personality
0.24
Very relaxed 9 (13%) 7 (9%)
Fairly relaxed 24 (33%) 24 (32%)
Average 17 (24%) 30 (39%)
Prone to stress 19 (26%) 14 (18%)
Anxiety/depression at 1
month
18 (27%)† 18 (26%) 0.85
*Age left education n68; †Anxiety and depression n66.
Table 3. Medications Between Strokes and TIA
Stroke, n73
n (%)
TIA, n76
n (%)
Stroke vs TIA
P
Before event
Antiplatelet 37 (51%) 29 (38%) 0.14
Warfarin 4 (5%) 6 (8%) 0.75
Antihypertensive 47 (64%) 39 (51%) 0.14
Beta-blocker 21 (29%) 23 (30%) 0.86
Statin 20 (27%) 15 (20%) 0.33
At 6 mo
Antiplatelet 60 (82%) 69 (91%) 0.15
Warfarin 6 (8%) 7 (9%) 1.00
Antihypertensive 56 (77%) 52 (69%) 0.28
Beta-blocker 21 (29%) 22 (29%) 1.00
Statin 64 (88%) 64 (84%) 0.64
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consistent with our findings, they also found that rates of
fatigue were positively correlated with the NIHSS score
(P0.004).33
Previous studies have also demonstrated a positive rela-
tionship between fatigue and increased modified Rankin
score at the time of assessment.3,32,33 However, in our study
even stroke patients with a modified Rankin score of 0 were
more fatigued than patients with TIA. Furthermore, even
stroke patients with initial NIHSS score of 0 (ie, very minor
strokes at onset) still reported more fatigue than TIA patients.
Similarly, fatigue is often considered to be a symptom of
depression, although previous studies are conflict-
ing.11,14,16,32,33 However, the majority of patients in our study
felt fatigued without depression. It is therefore likely that
fatigue and depression are separate, albeit overlapping,
constructs.
Our study does have some limitations. First, there is no
gold standard for the measurement of fatigue.32,34,35 However,
the Chalder fatigue scale has been used previously in studies
of patients with neurological conditions36 and has been shown
to be valid and reliable in multiple different disease states25–29
and in the general population.30,37 Rates of fatigue, defined as
a Chalder score 3, of 10% to 18% have been reported in
healthy younger populations, increasing to 22% in the general
population older than 6038,39 Thus, our stroke patients were
more fatigued than would be expected in the general popu-
lation of a similar age, whereas the TIA patients were
probably not. Second, we only assessed some of the poten-
tially confounding factors at baseline, such as blood tests,
soon after the TIA or stroke, whereas we measured fatigue at
6-month follow-up. However, several other potential con-
founders, such as medication, anxiety, depression, and phys-
ical functioning, were measured at the 6-month follow-up.
Third, anxiety and depression were not measured in any great
detail; therefore, future studies using more sensitive measures
would be appropriate. Fourth, our stroke patients were more
likely to have had a previous stroke than the TIA patients.
However, the excess of fatigue was still seen in incident
strokes and all stroke patients were independent in self-care,
even though they had experienced a previous event. Finally,
we tried to use TIA patients as nonstroke controls to deter-
mine whether there might be central mechanisms consequent
on having a stroke underlying fatigue and to minimize the
various sources of confounding discussed, but we did not
have MR brain imaging in all cases. Therefore, we cannot
separate those TIA cases with and without a clinically
appropriate cerebral infarct, or those with asymptomatic
previous infarction. However, we found significant differ-
ences between minor strokes and TIA despite this limitation.
It is possible that rates of fatigue would have been even lower
in TIA patients with no infarction.
In conclusion, the prevalence of fatigue after minor stroke
is higher than after TIA, suggesting that it is not simply a
Figure. Comparison of Chalder fatigue
score in TIA and minor stroke.
Table 4. Functional Scores, Simple Questions, Modified
Rankin Score, NIHSS, and Anxiety/Depression at 6 Months
Stroke
n (%)
TIA
n (%)
Stroke vs TIA
P
Chalder, median (IQR) 4 (0, 7) 1 (0, 4) 0.0013
Excluding cases with
previous stroke
Chalder, median (IQR) 4 (0, 7) 1.5 (0, 4) 0.008
All cases
Fatigue (Chalder 3) 41 (56%) 22 (29%) 0.0008
Excluding cases with
previous stroke
Fatigue (Chalder 3) 31 (53%) 22 (30%) 0.008
Barthel, median (IQR) 20 (20, 20) 20 (20, 20) 0.16
MMSE, median (IQR) 27 (26, 29) 27.5 (26, 29) 0.48
Simple Questions
Need help at 6 mo 7 (10%) 1 (1%) 0.030
Have problems at 6 mo 43 (60%) 8 (11%) 0.0001
Made a full recovery at
6 mo
32 (44%) 71 (93%) 0.0001
Modified Rankin score,
median (IQR)
1(0,1) 0 (0,1) 0.0002
NIHSS by fatigue
NIHSS 4 13 (87%)
NIHSS 3 28 (48%) 0.0087
NIHSS0 13 (57%) 22 (29%) 0.015
Anxiety/depression at
6 mo
20 (30%)* 20 (27%) 0.85
MMSE indicates Mini-Mental State Examination.
P values are for Mann–Whitney U test for medians and Fisher exact test for
frequencies unless stated otherwise.
*Anxiety and depression n67.
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consequence of the stress of a recent acute cerebral event,
comorbidity, medication, or other potential confounders. The
high levels of fatigue in stroke patients without neurological
impairment suggest it has a central origin rather than being
the result of increased physical effort required after stroke.
Monitoring fatigue and identifying interventions such as
centrally acting pharmacological interventions may be an
appropriate avenue for future study and may improve
outcomes.
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